Cel Sci (CVM) Current Assets (2010 - 2026)
Cel Sci's Current Assets was $7.5 million in fiscal Q3 2026 (quarter ended Jun 30, 2026), up 186.1% from $2.62 million a year earlier and up 159.3% from the prior quarter.
Cel Sci (CVM) Current Assets (2010 - 2026) Analysis & Trends
At the end of FY2025 (ended Sep 30, 2025), Current Assets at Cel Sci came in at $11.6 million, up 91.5% from FY2024.
- Current Assets shows a five-year compound annual growth rate of -8.1% (FY2020 to FY2025).
- In earlier fiscal years, Current Assets was $6.06 million in FY2024 (-12.5%), $6.92 million in FY2023 (-72.8%), $25.44 million in FY2022 (-43.8%) and $45.27 million in FY2021 (+155.8%).
- Quarterly Current Assets has moved between $2.62 million (fiscal Q3 2025) and $45.27 million (fiscal Q4 2021) over five years.
- Compared with a year earlier, Current Assets was higher in three of the last eight quarters, with growth averaging 23.2%.
- The best year-over-year quarter for Current Assets over five years was fiscal Q3 2026 (growth of 186.1%); the worst was fiscal Q3 2023 (a decline of 75.0%).
- Per Business Quant data, CVM's Current Assets in the three fiscal quarters before Q3 2026 was $2.89 million (Q2 2026), $7.03 million (Q1 2026) and $11.6 million (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 59.77 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 33.67 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 36.68 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 27.35 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 27.97 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.96 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 13.95 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 41.36 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 12.54 Bn |
| 10 | Cel Sci | 3.11 Mn | -22.54 Mn | - | 7.50 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.50 Mn |
| Mar 31, 2026 | 2.89 Mn |
| Dec 31, 2025 | 7.03 Mn |
| Sep 30, 2025 | 11.60 Mn |
| Jun 30, 2025 | 2.62 Mn |
| Mar 31, 2025 | 3.02 Mn |
| Dec 31, 2024 | 5.86 Mn |
| Sep 30, 2024 | 6.06 Mn |
| Jun 30, 2024 | 3.54 Mn |
| Mar 31, 2024 | 8.51 Mn |
| Dec 31, 2023 | 6.15 Mn |
| Sep 30, 2023 | 6.92 Mn |
| Jun 30, 2023 | 7.73 Mn |
| Mar 31, 2023 | 12.57 Mn |
| Dec 31, 2022 | 20.40 Mn |
| Sep 30, 2022 | 25.44 Mn |
| Jun 30, 2022 | 30.96 Mn |
| Mar 31, 2022 | 37.28 Mn |
| Dec 31, 2021 | 41.87 Mn |
| Sep 30, 2021 | 45.27 Mn |
Cel Sci Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=CVM&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "CVM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=CVM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();